Advertisement

Reactions Weekly

, Volume 1730, Issue 1, pp 19–19 | Cite as

Alectinib/crizotinib

Diarrhoea and acquired resistance in lung adenocarcinoma: case report
Case report
  • 9 Downloads

Reference

  1. Song P, et al. Alectinib treatment response in lung adenocarcinoma patient with novel EML4-ALK variant. Thoracic Cancer 9: 1327-1332, No. 10, Oct 2018. Available from: URL: http://doi.org/10.1111/1759-7714.12834 - China

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations